A randomized phase II trial assessing irinotecan (IRI) and 5FU/folinic acid (LV), “Mayo regimen”, in first line palliative chemotherapy patients (pts) with metastatic colorectal cancer (MCRC)
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S70
- https://doi.org/10.1016/s0959-8049(99)80646-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: